Insights

Market Expansion The Schwabe Group is actively expanding its global footprint by entering new markets and increasing access to its phytomedicine products, presenting opportunities to collaborate with distribution partners and healthcare providers in emerging regions.

Innovative Portfolio Focusing on plant-based medicines and health products, Schwabe’s commitment to innovation and phytomedicine development positions it as a key player for health practitioners seeking natural, complex treatment options for age-related and multisystem diseases.

Acquisition Strategy With recent acquisition of Brain Effect, Schwabe demonstrates a strategy to diversify and strengthen its health solutions portfolio, creating potential cross-selling opportunities with existing distribution channels.

Sustainability Focus Schwabe’s emphasis on sustainability through plant-based medicines aligns with the growing consumer demand for eco-friendly health products, enabling potential partnerships with eco-conscious retailers and wellness platforms.

Leadership and Growth As a well-established company with a history spanning over 150 years and significant revenue, Schwabe presents opportunities to engage with key decision-makers focused on continued innovation and market leadership in phytomedicines.

Similar companies to Schwabe Group

Schwabe Group Tech Stack

Schwabe Group uses 8 technology products and services including Usercentrics, Open Graph, Sieben, and more. Explore Schwabe Group's tech stack below.

  • Usercentrics
    Consent Management
  • Open Graph
    Content Management System
  • Sieben
    Marketing Analytics
  • Priority Hints
    Performance
  • Acquia Cloud
    Platform As A Service
  • PHP
    Programming Languages
  • Python
    Programming Languages
  • Max Mega Menu
    Widgets

Schwabe Group's Email Address Formats

Schwabe Group uses at least 2 format(s):
Schwabe Group Email FormatsExamplePercentage
First.Last@schwabe-group.comJohn.Doe@schwabe-group.com
94%
FirstLast@schwabe-group.comJohnDoe@schwabe-group.com
2%
First_L@schwabe-group.comJohn_D@schwabe-group.com
2%
Last.F@schwabe-group.comDoe.J@schwabe-group.com
2%
First.Last@schwabepharma.comJohn.Doe@schwabepharma.com
27%
First@schwabepharma.comJohn@schwabepharma.com
18%
LastFirst@schwabepharma.comDoeJohn@schwabepharma.com
19%
Last.First@schwabepharma.comDoe.John@schwabepharma.com
18%
FirstL@schwabepharma.comJohnD@schwabepharma.com
9%
LastF@schwabepharma.comDoeJ@schwabepharma.com
9%

Frequently Asked Questions

What is Schwabe Group's official website and social media links?

Minus sign iconPlus sign icon
Schwabe Group's official website is schwabe-group.com and has social profiles on LinkedIn.

How much revenue does Schwabe Group generate?

Minus sign iconPlus sign icon
As of December 2025, Schwabe Group's annual revenue is estimated to be $5B.

What is Schwabe Group's NAICS code?

Minus sign iconPlus sign icon
Schwabe Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Schwabe Group have currently?

Minus sign iconPlus sign icon
As of December 2025, Schwabe Group has approximately 1K employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: O. S.Cco: A. B.Chief Legal, Compliance & Human Resources Officer: J. A. T.. Explore Schwabe Group's employee directory with LeadIQ.

What industry does Schwabe Group belong to?

Minus sign iconPlus sign icon
Schwabe Group operates in the Pharmaceutical Manufacturing industry.

What technology does Schwabe Group use?

Minus sign iconPlus sign icon
Schwabe Group's tech stack includes UsercentricsOpen GraphSiebenPriority HintsAcquia CloudPHPPythonMax Mega Menu.

What is Schwabe Group's email format?

Minus sign iconPlus sign icon
Schwabe Group's email format typically follows the pattern of First.Last@schwabe-group.com. Find more Schwabe Group email formats with LeadIQ.

Schwabe Group

Pharmaceutical ManufacturingBaden-württemberg, Germany1001-5000 Employees

The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the Group focus on plants as the basis for developing pharmaceuticals and health products.
 
The original form of the Group’s parent company, which is now Dr. Willmar Schwabe GmbH & Co. KG, is one of the oldest pharmaceutical manufacturers in Europe and has a company history dating back over 150 years.

We do so by researching and developing plant-based medicines and health-care products. Our goal is to create value through innovation. We believe that innovative phytomedicines will become increasingly important over the next few decades.
By influencing several target systems in the body at the same time, they may be more appropriate for patients suffering from complex or age-related diseases than is the “silver bullet” approach of synthetic medicines.

In the future, phytomedicines will help people, worldwide, to lead a sustainable, productive and healthy life. We are actively shaping the company’s international future in a changing and challenging global market. Our goal is to maintain our market-leadership in phytomedicines by introducing our products into new markets, expanding our network of affiliates and distribution partners, and providing more extensive access to our health-care solutions.

The commitment, experience and creativity of our employees are the source of our success. At Schwabe Pharmaceuticals we share a common vision: “From Nature. For Health”. We would like to invite you to learn more about this vision and our company on this website.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $250M$500M

    Schwabe Group's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Schwabe Group's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.